Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
posted on
Dec 02, 2019 02:42PM
Good Endpoints article on Biogen.
Also, forgive my perpetuation of confusion. Biogen's Aducanumab and BAN2401 are two separate drugs that both tackle amyloid. I previously implied that they were one and the same.
BearDownAZ